Shivani Srivastava MD
Hematologic Oncology
Vice President, Cell Therapy Development, Bristol Myers Squibb
Join to View Full Profile
Bristol Myers Squibb3401 Princeton PikeLawrence Township, NJ 08648
Dr. Srivastava is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2004 - 2007
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2003 - 2004
SUNY Upstate Medical UniversityResidency, Internal Medicine, 2001 - 2003
Kasturba Medical College ManipalClass of 2000
Certifications & Licensure
IN State Medical License 2008 - 2013
Clinical Trials
- Fludarabine, Velcade and Rituximab for Relapsed or Refractory Follicular Non-Hodgkin Lymphoma Start of enrollment: 2010 Oct 01
Publications & Presentations
PubMed
- 47 citationsInhibition of LSD1 with Bomedemstat Sensitizes Small Cell Lung Cancer to Immune Checkpoint Blockade and T-Cell Killing.Joseph B Hiatt, Holly Sandborg, Sarah M Garrison, Henry U Arnold, Sheng-You Liao
Clinical Cancer Research. 2022-10-14 - 3 citationsTreatment patterns and outcomes following disease progression on anti-PD-1 therapies for advanced melanoma.Beth L Nordstrom, Melissa Hamilton, Jenna M Collins, Dennis Earle, Ying Zhang
Future Oncology. 2022-04-01 - 826 citationsRelatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma.Hussein A Tawbi, Dirk Schadendorf, Evan J Lipson, Paolo A Ascierto, Luis Matamala
The New England Journal of Medicine. 2022-01-06
Grant Support
- Improving CAR-T efficacy against solid tumors by expanding lymph node reservoirs of “stem-like” CAR-T cellsFRED HUTCHINSON CANCER CENTER2023–2028
Industry Relationships
- Vice President, Bristol Myers Squibb
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
